Acetaminophen 325 MG / diphenhydramine hydrochloride 25 MG / phenylephrine hydrochloride 5... — RxCUI 1046751
RxNorm drug concept · Semantic clinical drug
RxCUI 1046751
Semantic clinical drug · SCD
● Current RxNorm concept 3 FDA products
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1046751
Official nameAcetaminophen 325 MG / diphenhydramine hydrochloride 25 MG / phenylephrine hydrochloride 5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asAPAP 325 MG / diphenhydramine hydrochloride 25 MG / phenylephrine hydrochloride 5 MG Oral Tablet; acetaminophen 325 MG / diphenhydrAMINE HCl 25 MG / phenylephrine HCl 5 MG Oral Tablet
FDA products mapped3
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Diphenhydramine Topical: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It gives temporary relief of pain and itching on the skin. That includes minor burns, minor cuts or scrapes, insect bites, minor skin irritations, and rashes from poison ivy, oak o...
- Adults and children 2 and older can apply it to the affected area no more than 3 to 4 times a day. Don't use it more often than directed. For a child under 2, check with a doctor f...
- No. Don't use it on large areas of the body or on broken, blistered or oozing skin. Also avoid it on chicken pox or sunburn.
- Can I put it on a large area or on blistered skin?
🕸️ Concept Web — How Acetaminophen 325 MG / diphenhydramine hydrochlo... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Acetaminophen 325 MG / diphenhydramine hydrochloride 25 MG / phenylephrine hydrochloride 5 MG Oral Tablet
RxCUI 1046751 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 6
The active substance itself — no strength, form, or brand attached yet.
-
Acetaminophen
161IN -
Diphenhydramine
3498IN -
Phenylephrine
8163IN -
Acetaminophen / diphenhydramine / phenylephrine
689785MIN -
Diphenhydramine hydrochloride
1362PIN -
Phenylephrine hydrochloride
8164PIN
-
Acetaminophen
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Acetaminophen / diphenhydramine / phenylephrine Oral Tablet
602581SCDF -
Acetaminophen / diphenhydramine hydrochloride / phenylephrine hydrochloride Oral Tablet
2647775SCDFP -
Acetaminophen / diphenhydramine / phenylephrine Oral Product
1151196SCDG -
Acetaminophen / diphenhydramine / phenylephrine Pill
1151197SCDG -
Acetaminophen / diphenhydramine hydrochloride / phenylephrine hydrochloride Oral Product
2659765SCDGP -
Acetaminophen / diphenhydramine hydrochloride / phenylephrine hydrochloride Pill
2661678SCDGP -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Acetaminophen / diphenhydramine / phenylephrine Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Acetaminophen 325 MG
315263SCDC -
Diphenhydramine hydrochloride 25 MG
901813SCDC -
Phenylephrine hydrochloride 5 MG
1020198SCDC
-
Acetaminophen 325 MG
-
Packs 2
Fixed collections of drugs packaged and sold together, like dose packs.
-
{1 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG / phenylephrine hydrochloride 5 MG Oral Tablet) / 1 (acetaminophen 325 MG / diphenhydramine hydrochloride 25 MG / phenylephrine hydrochloride 5 MG Oral Tablet) } Pack
2634562GPCK -
{1 (acetaminophen 325 MG / diphenhydramine hydrochloride 25 MG / phenylephrine hydrochloride 5 MG Oral Tablet) / 1 (acetaminophen 325 MG / guaifenesin 200 MG / phenylephrine hydrochloride 5 MG Oral Tablet) } Pack
2634818GPCK
-
{1 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG / phenylephrine hydrochloride 5 MG Oral Tablet) / 1 (acetaminophen 325 MG / diphenhydramine hydrochloride 25 MG / phenylephrine hydrochloride 5 MG Oral Tablet) } Pack
Showing up to 8 concepts per family — 19 of 20 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Acetaminophen 325 MG
SCDC · 315263 -
Diphenhydramine hydrochloride 25 MG
SCDC · 901813 -
Phenylephrine hydrochloride 5 MG
SCDC · 1020198 -
Acetaminophen / diphenhydramine / phenylephrine Oral Tablet
SCDF · 602581 -
Acetaminophen / diphenhydramine hydrochloride / phenylephrine hydrochloride Oral Tablet
SCDFP · 2647775 -
Acetaminophen / diphenhydramine / phenylephrine Oral Product
SCDG · 1151196 -
Acetaminophen / diphenhydramine / phenylephrine Pill
SCDG · 1151197 -
Acetaminophen / diphenhydramine hydrochloride / phenylephrine hydrochloride Oral Product
SCDGP · 2659765 -
Acetaminophen / diphenhydramine hydrochloride / phenylephrine hydrochloride Pill
SCDGP · 2661678 -
{1 (acetaminophen 325 MG / dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG / phenylephrine hydrochloride 5 MG Oral Tablet) / 1 (acetaminophen 325 MG / diphenhydramine hydrochloride 25 MG / phenylephrine hydrochloride 5 MG Oral Tablet) } Pack
GPCK · 2634562
📦 FDA Products & Package NDCs
3 products · 4 package NDCs
4 package NDCs map to RxCUI 1046751 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00363-5430-09 | 2 BLISTER PACK in 1 CARTON (0363-5430-09) / 10 TABLET, FILM... | Allergy Relief | Walgreen Company | 2021-11-04 |
| 49035-0543-09 | 2 BLISTER PACK in 1 CARTON (49035-543-09) / 10 TABLET, FILM... | Severe Allergy Plus Sinus Headache | Wal-Mart Stores Inc | 2007-06-27 |
| 49035-0543-41 | 10 TABLET, FILM COATED in 1 BLISTER PACK (49035-543-41) | Severe Allergy Plus Sinus Headache | Wal-Mart Stores Inc | 2007-06-27 |
| 59779-0543-09 | 2 BLISTER PACK in 1 CARTON (59779-543-09) / 10 TABLET, FILM... | Severe Allergy And Sinus Headache Maximum Strength | CVS Pharmacy | 2007-06-27 |
Observed labelers:
Wal-Mart Stores Inc (2) ·
CVS Pharmacy (1) ·
Walgreen Company (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.